BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 16161348)

  • 1. Long-term stability of propofol in human plasma and blood in different storage conditions.
    Bienert A; Zaba Z; Dyderski S; Ogrodowicz M; Drobnik L
    Acta Pol Pharm; 2005; 62(2):95-7. PubMed ID: 16161348
    [No Abstract]   [Full Text] [Related]  

  • 2. A rapid and simple HPLC method for the analysis of propofol in biological fluids.
    Cussonneau X; De Smet E; Lantsoght K; Salvi JP; Bolon-Larger M; Boulieu R
    J Pharm Biomed Anal; 2007 Jul; 44(3):680-2. PubMed ID: 17129698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromatographic assay and pharmacokinetic studies of propofol in human serum.
    Emara S; Saleh G; Fathy M; Bakr MA
    Biomed Chromatogr; 1999 Jun; 13(4):299-303. PubMed ID: 10416064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPLC investigation of free and bound propofol in human plasma and cerebrospinal fluid.
    Dawidowicz AL; KalityƄski R
    Biomed Chromatogr; 2003 Oct; 17(7):447-52. PubMed ID: 14598328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of blood sample storage time on the propofol concentration in plasma and solid blood elements.
    Dawidowicz AL; Fijalkowska A; Nestorowicz A; Fornal E
    Biomed Chromatogr; 2001 Oct; 15(6):408-12. PubMed ID: 11559926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determining the influence of storage time on the level of propofol in blood samples by means of chromatography.
    Dawidowicz AL; Fornal E; Fijalkowska A
    Biomed Chromatogr; 2000 Jun; 14(4):249-55. PubMed ID: 10861736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of propofol in low-volume samples by high-performance liquid chromatography with fluorescence detection.
    Knibbe CA; Koster VS; Deneer VH; Stuurman RM; Kuks PF; Lange R
    J Chromatogr B Biomed Sci Appl; 1998 Mar; 706(2):305-10. PubMed ID: 9551817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of whole blood and plasma ascorbic acid.
    Karlsen A; Blomhoff R; Gundersen TE
    Eur J Clin Nutr; 2007 Oct; 61(10):1233-6. PubMed ID: 17299479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The advantages of cell lysis before blood sample preparation by extraction for HPLC propofol analysis.
    Dawidowicz AL; Fornal E
    Biomed Chromatogr; 2000 Nov; 14(7):493-7. PubMed ID: 11113931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of intralipid on free propofol fraction assayed in human serum albumin solutions and human plasma.
    Kalitynski R; Dawidowicz AL; Poszytek J
    Acta Pharmacol Sin; 2006 Dec; 27(12):1637-41. PubMed ID: 17112420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fospropofol assay issues and impact on pharmacokinetic and pharmacodynamic evaluation.
    Shah A; Mistry B; Gibiansky E; Gibiansky L
    Anesth Analg; 2009 Jan; 108(1):382; author reply 382-3. PubMed ID: 19095885
    [No Abstract]   [Full Text] [Related]  

  • 12. [Determination of propofol in human serum by improved reversed phase high-performance liquid chromatography with fluorescence detection].
    Fan YY; Xu LX; Wen AD; Zhang H; Liu CR; Li W; Mei XP
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Oct; 26(10):1510-2. PubMed ID: 17062366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of administration rate on propofol plasma-effect site equilibration.
    Struys MM; Coppens MJ; De Neve N; Mortier EP; Doufas AG; Van Bocxlaer JF; Shafer SL
    Anesthesiology; 2007 Sep; 107(3):386-96. PubMed ID: 17721240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma concentration for optimal sedation and total body clearance of propofol in patients after esophagectomy.
    Takizawa D; Sato E; Nishikawa K; Hinohara H; Hiraoka H; Saito S; Goto F; Kunimoto F
    J Anesth; 2005; 19(1):88-90. PubMed ID: 15674525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propofol effect-site concentrations: hunt the k(e0).
    Glen JB
    Anesth Analg; 2013 Aug; 117(2):535-6. PubMed ID: 23881380
    [No Abstract]   [Full Text] [Related]  

  • 16. [Using of chromatographical methods to study stability, pharmacokinetics and metabolism of propofol (review)].
    Adeishvili-Anguladze LV; Makharadze RV; Kurtsikidze MSh; Abuladze NB; Gabuniia KU
    Georgian Med News; 2009 May; (170):95-100. PubMed ID: 19556652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences of propofol concentrations in mammalian whole blood and in corresponding plasma samples analyzed by high performance liquid chromatography.
    Grossherr M; Spies E; Scheel A; Hengstenberg A; Gehring H; Dibbelt L
    Clin Lab; 2007; 53(5-6):315-9. PubMed ID: 17605407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative measurement of propofol and in main glucuroconjugate metabolites in human plasma using solid phase extraction-liquid chromatography-tandem mass spectrometry.
    Cohen S; Lhuillier F; Mouloua Y; Vignal B; Favetta P; Guitton J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jul; 854(1-2):165-72. PubMed ID: 17485254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum cortisol level and depth of propofol-induced sedation.
    Miyawaki T; Kohjitani A; Maeda S; Kita F; Higuchi H; Shimada M
    Acta Anaesthesiol Scand; 2004 Mar; 48(3):384-5. PubMed ID: 14982577
    [No Abstract]   [Full Text] [Related]  

  • 20. Onset and offset pharmacodynamics of propofol.
    O'Halloran PL; Hosseini-Yeganeh M; McBride LJ; Ramzan I
    Pharmazie; 2004 Jan; 59(1):76-7. PubMed ID: 14964429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.